105 related articles for article (PubMed ID: 8290270)
1. The non-catalytic domain of ras-GAP inhibits transformation induced by G protein coupled receptors.
Xu N; McCormick F; Gutkind JS
Oncogene; 1994 Feb; 9(2):597-601. PubMed ID: 8290270
[TBL] [Abstract][Full Text] [Related]
2. Transformation suppressor activity of C3G is independent of its CDC25-homology domain.
Guerrero C; Fernandez-Medarde A; Rojas JM; Font de Mora J; Esteban LM; Santos E
Oncogene; 1998 Feb; 16(5):613-24. PubMed ID: 9482107
[TBL] [Abstract][Full Text] [Related]
3. Suppression of c-ras transformation by GTPase-activating protein.
Zhang K; DeClue JE; Vass WC; Papageorge AG; McCormick F; Lowy DR
Nature; 1990 Aug; 346(6286):754-6. PubMed ID: 2201922
[TBL] [Abstract][Full Text] [Related]
4. Different structural organization of Ras and Rho effector domains.
Self AJ; Paterson HF; Hall A
Oncogene; 1993 Mar; 8(3):655-61. PubMed ID: 8437849
[TBL] [Abstract][Full Text] [Related]
5. Muscarinic receptors transform NIH 3T3 cells through a Ras-dependent signalling pathway inhibited by the Ras-GTPase-activating protein SH3 domain.
Mattingly RR; Sorisky A; Brann MR; Macara IG
Mol Cell Biol; 1994 Dec; 14(12):7943-52. PubMed ID: 7969134
[TBL] [Abstract][Full Text] [Related]
6. Functional interactions between isolated SH2 domains and insulin/Ras signaling pathways of Xenopus oocytes: opposite effects of the carboxy- and amino-terminal SH2 domains of p85 PI 3-kinase.
Aroca P; Mahadevan D; Santos E
Oncogene; 1996 Nov; 13(9):1839-46. PubMed ID: 8934529
[TBL] [Abstract][Full Text] [Related]
7. A peptide from the GAP-binding domain of the ras-p21 protein and azatyrosine block ras-induced maturation of Xenopus oocytes.
Chung DL; Brandt-Rauf P; Murphy RB; Nishimura S; Yamaizumi Z; Weinstein IB; Pincus MR
Anticancer Res; 1991; 11(4):1373-8. PubMed ID: 1746893
[TBL] [Abstract][Full Text] [Related]
8. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
Michieli P; Li W; Lorenzi MV; Miki T; Zakut R; Givol D; Pierce JH
Oncogene; 1996 Feb; 12(4):775-84. PubMed ID: 8632899
[TBL] [Abstract][Full Text] [Related]
10. Complex formation between the p21ras GTPase-activating protein and phosphoproteins p62 and p190 is independent of p21ras signalling.
Pronk GJ; de Vries-Smits AM; Ellis C; Bos JL
Oncogene; 1993 Oct; 8(10):2773-80. PubMed ID: 8378086
[TBL] [Abstract][Full Text] [Related]
11. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
12. Expression of an ATP binding mutant of PKC-delta inhibits Sis-induced transformation of NIH3T3 cells.
Li W; Michieli P; Alimandi M; Lorenzi MV; Wu Y; Wang LH; Heidaran MA; Pierce JH
Oncogene; 1996 Aug; 13(4):731-7. PubMed ID: 8761294
[TBL] [Abstract][Full Text] [Related]
13. Cellular functions of TC10, a Rho family GTPase: regulation of morphology, signal transduction and cell growth.
Murphy GA; Solski PA; Jillian SA; Pérez de la Ossa P; D'Eustachio P; Der CJ; Rush MG
Oncogene; 1999 Jul; 18(26):3831-45. PubMed ID: 10445846
[TBL] [Abstract][Full Text] [Related]
14. The interplay between ras oncogenes and tumor suppressor genes in experimental carcinogenesis.
Balmain A; Brown K; Bremner R
Immunol Ser; 1990; 51():75-88. PubMed ID: 2128916
[No Abstract] [Full Text] [Related]
15. The small GTP-binding protein, Rhes, regulates signal transduction from G protein-coupled receptors.
Vargiu P; De Abajo R; Garcia-Ranea JA; Valencia A; Santisteban P; Crespo P; Bernal J
Oncogene; 2004 Jan; 23(2):559-68. PubMed ID: 14724584
[TBL] [Abstract][Full Text] [Related]
16. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav.
Crespo P; Bustelo XR; Aaronson DS; Coso OA; Lopez-Barahona M; Barbacid M; Gutkind JS
Oncogene; 1996 Aug; 13(3):455-60. PubMed ID: 8760286
[TBL] [Abstract][Full Text] [Related]
17. Induced direct binding of the adapter protein Nck to the GTPase-activating protein-associated protein p62 by epidermal growth factor.
Tang J; Feng GS; Li W
Oncogene; 1997 Oct; 15(15):1823-32. PubMed ID: 9362449
[TBL] [Abstract][Full Text] [Related]
18. Ras-GTPase activating protein inhibition specifically induces apoptosis of tumour cells.
Leblanc V; Delumeau I; Tocqué B
Oncogene; 1999 Aug; 18(34):4884-9. PubMed ID: 10490822
[TBL] [Abstract][Full Text] [Related]
19. Nonsense mutations in the C-terminal SH2 region of the GTPase activating protein (GAP) gene in human tumours.
Friedman E; Gejman PV; Martin GA; McCormick F
Nat Genet; 1993 Nov; 5(3):242-7. PubMed ID: 8275088
[TBL] [Abstract][Full Text] [Related]
20. Rho small G protein and cytoskeletal control.
Takai Y; Kaibuchi K; Sasaki T; Tanaka K; Shirataki H; Nakanishi H
Princess Takamatsu Symp; 1994; 24():338-50. PubMed ID: 8983086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]